Figure 1From: Serum S100B in primary progressive multiple sclerosis patients treated with interferon-beta-1aFifty subjects with PPMS were randomised in a phase II trial of Interferon β-1a and were assessed 3 monthly over a 2-year study period. n = number of subjects with PPMSBack to article page